688105 诺唯赞
已收盘 03-20 15:00:01
资讯
新帖
简况
每周股票复盘：诺唯赞（688105）已回购127,703股耗资近300万
证券之星 · 03-08
每周股票复盘：诺唯赞（688105）已回购127,703股耗资近300万
诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，3月2日股价下跌3.42%
证券之星 · 03-02
诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，3月2日股价下跌3.42%
每周股票复盘：诺唯赞（688105）2025年净亏1697万同比减亏
证券之星 · 03-01
每周股票复盘：诺唯赞（688105）2025年净亏1697万同比减亏
诺唯赞（688105）披露2025年度业绩快报，2月26日股价下跌0.94%
证券之星 · 02-26
诺唯赞（688105）披露2025年度业绩快报，2月26日股价下跌0.94%
诺唯赞(688105.SH)2025年度归母净亏损1697.02万元
智通财经 · 02-26
诺唯赞(688105.SH)2025年度归母净亏损1697.02万元
每周股票复盘：诺唯赞（688105）已回购127,703股耗资近300万
证券之星 · 02-08
每周股票复盘：诺唯赞（688105）已回购127,703股耗资近300万
诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，2月2日股价下跌2.0%
证券之星 · 02-02
诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，2月2日股价下跌2.0%
每周股票复盘：诺唯赞（688105）预计2025年净利亏损1000万至2000万元
证券之星 · 02-01
每周股票复盘：诺唯赞（688105）预计2025年净利亏损1000万至2000万元
诺唯赞（688105）披露2025年年度业绩预告，1月29日股价下跌1.18%
证券之星 · 01-29
诺唯赞（688105）披露2025年年度业绩预告，1月29日股价下跌1.18%
诺唯赞(688105.SH)发预亏，预计2025年度归母净亏损1000万元至2000万元
智通财经 · 01-29
诺唯赞(688105.SH)发预亏，预计2025年度归母净亏损1000万元至2000万元
每周股票复盘：诺唯赞（688105）回购进展披露，已支付近300万元
证券之星 · 01-11
每周股票复盘：诺唯赞（688105）回购进展披露，已支付近300万元
诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，01月05日股价上涨2.35%
证券之星 · 01-05
诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，01月05日股价上涨2.35%
每周股票复盘：诺唯赞（688105）股东减持318.58万股触及1%变动
证券之星 · 2025-12-28
每周股票复盘：诺唯赞（688105）股东减持318.58万股触及1%变动
12月24日诺唯赞发布公告，股东减持0.06万股
证券之星 · 2025-12-24
12月24日诺唯赞发布公告，股东减持0.06万股
12月22日诺唯赞发布公告，股东减持318.58万股
证券之星 · 2025-12-22
12月22日诺唯赞发布公告，股东减持318.58万股
诺唯赞（688105）披露公司产品取得欧盟CE IVDR认证，12月17日股价下跌0.1%
证券之星 · 2025-12-17
诺唯赞（688105）披露公司产品取得欧盟CE IVDR认证，12月17日股价下跌0.1%
诺唯赞(688105.SH)六项呼吸道病原体核酸检测试剂盒取得欧盟CE IVDR认证
智通财经 · 2025-12-17
诺唯赞(688105.SH)六项呼吸道病原体核酸检测试剂盒取得欧盟CE IVDR认证
诺唯赞（688105）披露控股子公司增资扩股暨引入外部投资者公告，12月08日股价下跌0.14%
证券之星 · 2025-12-08
诺唯赞（688105）披露控股子公司增资扩股暨引入外部投资者公告，12月08日股价下跌0.14%
诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，12月1日股价下跌1.14%
证券之星 · 2025-12-01
诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，12月1日股价下跌1.14%
诺唯赞（688105）披露控股子公司增资扩股暨引入外部投资者公告，11月26日股价上涨0.26%
证券之星 · 2025-11-26
诺唯赞（688105）披露控股子公司增资扩股暨引入外部投资者公告，11月26日股价上涨0.26%
公司概况
公司名称：
南京诺唯赞生物科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2021-11-15
主营业务：
南京诺唯赞生物科技股份有限公司的主营业务是酶、抗原、抗体等生物制品的研发、生产和销售。公司的主要产品是生物试剂、POCT诊断试剂和仪器。截至2025年6月30日，公司共获得121项发明专利授权，发明专利申请累计269项。
发行价格：
55.00
{"stockData":{"symbol":"688105","market":"SH","secType":"STK","nameCN":"诺唯赞","latestPrice":19.64,"timestamp":1773990001000,"preClose":19.9,"halted":0,"volume":1320738,"delay":0,"changeRate":-0.0131,"floatShares":398000000,"shares":398000000,"eps":-0.0746,"marketStatus":"已收盘","change":-0.26,"latestTime":"03-20 15:00:01","open":20,"high":20.15,"low":19.63,"amount":26232800,"amplitude":0.0261,"askPrice":19.64,"askSize":49,"bidPrice":19.63,"bidSize":5,"shortable":0,"etf":0,"ttmEps":-0.0746,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":5,"adr":0,"adjPreClose":19.9,"symbolType":"stock_kcb","openAndCloseTimeList":[[1773970200000,1773977400000],[1773982800000,1773990000000]],"highLimit":21.89,"lowLimit":17.91,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":397734544,"isCdr":false,"pbRate":2.03,"roa":"--","roe":"0.17%","epsLYR":-0.05,"committee":-0.455253,"marketValue":7812000000,"turnoverRate":0.0033,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-03-23。","afterMarket":{"amount":0,"volume":0,"close":19.64,"buyVolume":0,"sellVolume":0,"time":1773992037559,"indexStatus":"已收盘 03-20 15:30:00","preClose":19.9},"floatMarketCap":7812000000},"requestUrl":"/m/hq/s/688105/wiki","defaultTab":"wiki","newsList":[{"id":"2617663850","title":"每周股票复盘：诺唯赞（688105）已回购127,703股耗资近300万","url":"https://stock-news.laohu8.com/highlight/detail?id=2617663850","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617663850?lang=zh_cn&edition=full","pubTime":"2026-03-08 02:43","pubTimestamp":1772908990,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，诺唯赞报收于20.27元，较上周的21.05元下跌3.71%。本周，诺唯赞3月2日盘中最高价报20.8元。诺唯赞当前最新总市值80.62亿元，在生物制品板块市值排名33/51，在两市A股市值排名2453/5190。本周关注点公司公告汇总：诺唯赞已累计回购127,703股，支付资金总额2,999,704.25元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800000881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"gpt_icon":0},{"id":"2616359195","title":"诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，3月2日股价下跌3.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616359195","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616359195?lang=zh_cn&edition=full","pubTime":"2026-03-02 23:36","pubTimestamp":1772465773,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，诺唯赞报收于20.33元，较前一交易日下跌3.42%，最新总市值为80.86亿元。近日，诺唯赞发布《关于以集中竞价交易方式回购公司股份的进展公告》。公告显示，南京诺唯赞生物科技股份有限公司于2025年6月19日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案，回购金额为500万元至1000万元，用于员工持股计划或股权激励，回购价格不超过30元/股，实施期限为2025年6月19日至2026年6月18日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200040685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2616845225","title":"每周股票复盘：诺唯赞（688105）2025年净亏1697万同比减亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2616845225","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616845225?lang=zh_cn&edition=full","pubTime":"2026-03-01 03:05","pubTimestamp":1772305513,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，诺唯赞报收于21.05元，较上周的20.78元上涨1.3%。本周，诺唯赞2月25日盘中最高价报21.23元。诺唯赞当前最新总市值83.72亿元，在生物制品板块市值排名33/51，在两市A股市值排名2441/5189。本周关注点业绩披露要点：诺唯赞2025年归属净利润亏损1,697.02万元，同比有所减亏。公司公告汇总：诺唯赞发布2025年度业绩快报，营业总收入137,788.13万元与同期基本持平。报告期末总资产为491,959.27万元，较期初下降2.56%；归属于母公司的所有者权益为379,571.91万元，同比下降3.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100001163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2614256870","title":"诺唯赞（688105）披露2025年度业绩快报，2月26日股价下跌0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614256870","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614256870?lang=zh_cn&edition=full","pubTime":"2026-02-26 23:09","pubTimestamp":1772118555,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘，诺唯赞报收于20.99元，较前一交易日下跌0.94%，最新总市值为83.48亿元。该股当日开盘21.21元，最高21.21元，最低20.79元，成交额达2433.59万元，换手率为0.29%。报告期末总资产为491,959.27万元，较期初下降2.56%；归属于母公司的所有者权益为379,571.91万元，同比下降3.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600037713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2614043400","title":"诺唯赞(688105.SH)2025年度归母净亏损1697.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614043400","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614043400?lang=zh_cn&edition=full","pubTime":"2026-02-26 19:44","pubTimestamp":1772106251,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺唯赞(688105.SH)发布2025年度业绩快报，报告期内,公司实现营业收入13.78亿元，与上年同期基本持平;实现归属于母公司所有者的净利润-1,697.02万元，实现归属于母公司所有者的扣除非经常性损益的净利润-7,936.03万元，均较上年同期减亏。报告期内，公司生物制品类产品的增值税税率由3%调整至13%，对整体营收与盈利产生较大不利影响。因未达成2023年限制性股票激励计划相关归属期业绩考核目标，公司于报告期末冲回对应归属期前期已计提的股份支付费用。同时，公司基于谨慎性原则，冲回部分前期已确认的递延所得税资产，所得税费用相应增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"诺唯赞(688105.SH)2025年度归母净亏损1697.02万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","688105"],"gpt_icon":0},{"id":"2609452616","title":"每周股票复盘：诺唯赞（688105）已回购127,703股耗资近300万","url":"https://stock-news.laohu8.com/highlight/detail?id=2609452616","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609452616?lang=zh_cn&edition=full","pubTime":"2026-02-08 03:06","pubTimestamp":1770491174,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，诺唯赞报收于20.89元，较上周的20.96元下跌0.33%。本周，诺唯赞2月5日盘中最高价报21.2元。诺唯赞当前最新总市值83.09亿元，在生物制品板块市值排名33/51，在两市A股市值排名2363/5186。本周关注点公司公告汇总：诺唯赞已累计回购127,703股，支付资金总额2,999,704.25元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800001101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"gpt_icon":0},{"id":"2608186091","title":"诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，2月2日股价下跌2.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608186091","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608186091?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:46","pubTimestamp":1770043582,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，诺唯赞报收于20.54元，较前一交易日下跌2.0%，最新总市值为81.69亿元。近日，诺唯赞发布《关于以集中竞价交易方式回购公司股份的进展公告》。公告显示，公司于2025年6月19日召开董事会，审议通过以集中竞价交易方式回购股份的方案，回购金额为500万元至1000万元，用于员工持股计划或股权激励，回购价格不超过30元/股，实施期限为2025年6月19日至2026年6月18日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200039549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"gpt_icon":0},{"id":"2608077766","title":"每周股票复盘：诺唯赞（688105）预计2025年净利亏损1000万至2000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608077766","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608077766?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:27","pubTimestamp":1769887629,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，诺唯赞报收于20.96元，较上周的22.0元下跌4.73%。本周，诺唯赞1月26日盘中最高价报22.93元。业绩披露要点诺唯赞发布业绩预告，预计2025年全年归属净利润亏损1000万元至2000万元。诺唯赞预计2025年全年扣非后净利润亏损7000万元至8500万元。公司公告汇总南京诺唯赞生物科技股份有限公司预计2025年度归属于母公司所有者的净利润为-2,000万元至-1,000万元，扣除非经常性损益后的净利润为-8,500万元至-7,000万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"gpt_icon":0},{"id":"2607403959","title":"诺唯赞（688105）披露2025年年度业绩预告，1月29日股价下跌1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607403959","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607403959?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:11","pubTimestamp":1769699472,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，诺唯赞报收于21.8元，较前一交易日下跌1.18%，最新总市值为86.71亿元。该股当日开盘21.84元，最高22.48元，最低21.55元，成交额达4843.45万元，换手率为0.55%。近日，南京诺唯赞生物科技股份有限公司发布2025年年度业绩预告。公告显示，公司预计2025年度归属于母公司所有者的净利润为-2,000万元至-1,000万元，扣除非经常性损益后的净利润为-8,500万元至-7,000万元。本次业绩预告未经注册会计师审计，最终数据以正式披露的2025年年度报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900044300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2607085722","title":"诺唯赞(688105.SH)发预亏，预计2025年度归母净亏损1000万元至2000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607085722","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607085722?lang=zh_cn&edition=full","pubTime":"2026-01-29 19:13","pubTimestamp":1769685209,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺唯赞(688105.SH)发布公告，公司预计2025年度实现归属于母公司所有者的净利润-2000万元至-1000万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399302.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"诺唯赞(688105.SH)发预亏，预计2025年度归母净亏损1000万元至2000万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","688105"],"gpt_icon":0},{"id":"2602536163","title":"每周股票复盘：诺唯赞（688105）回购进展披露，已支付近300万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602536163","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602536163?lang=zh_cn&edition=full","pubTime":"2026-01-11 04:00","pubTimestamp":1768075237,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，诺唯赞报收于21.41元，较上周的20.02元上涨6.94%。本周，诺唯赞1月9日盘中最高价报21.45元。本周关注点公司公告汇总：诺唯赞累计回购股份127,703股，已支付资金总额2,999,704.25元。公司将根据相关规定持续推进回购并履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100001292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2601500726","title":"诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，01月05日股价上涨2.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601500726","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601500726?lang=zh_cn&edition=full","pubTime":"2026-01-05 18:00","pubTimestamp":1767607204,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，诺唯赞报收于20.49元，较前一交易日上涨2.35%，最新总市值为81.5亿元。近日，诺唯赞发布关于以集中竞价交易方式回购公司股份的进展公告。公告显示，南京诺唯赞生物科技股份有限公司于2025年6月19日召开董事会，审议通过以自有资金回购股份的方案，回购金额为500万元至1000万元，用于员工持股计划或股权激励，回购价格不超过30元/股，期限为2025年6月19日至2026年6月18日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500027134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"gpt_icon":0},{"id":"2594242426","title":"每周股票复盘：诺唯赞（688105）股东减持318.58万股触及1%变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2594242426","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594242426?lang=zh_cn&edition=full","pubTime":"2025-12-28 04:17","pubTimestamp":1766866630,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，诺唯赞报收于19.9元，较上周的20.15元下跌1.24%。本周关注点股本股东变化：股东国寿成达减持318.58万股，持股比例由7.78%降至6.98%，权益变动触及1%刻度。12月22日公告显示，该股东于2025年11月12日至12月19日累计减持318.58万股，占总股本0.801%，期间股价下跌14.87%，截至12月19日收盘报20.15元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001055.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2593475595","title":"12月24日诺唯赞发布公告，股东减持0.06万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2593475595","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593475595?lang=zh_cn&edition=full","pubTime":"2025-12-24 17:45","pubTimestamp":1766569547,"startTime":"0","endTime":"0","summary":"证券之星消息，12月24日诺唯赞发布公告《诺唯赞:诺唯赞关于股东减持股份计划时间届满暨减持结果公告》，其股东国寿成达(上海)健康产业股权投资中心(有限合伙)于2025年12月20日至2025年12月23日间合计减持0.06万股，占公司目前总股本的0.0002%，变动期间该股股价下跌2.48%，截止12月23日收盘报19.65元。股东增减持详情见下表：根据诺唯赞2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400028706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2593863244","title":"12月22日诺唯赞发布公告，股东减持318.58万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2593863244","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593863244?lang=zh_cn&edition=full","pubTime":"2025-12-22 18:01","pubTimestamp":1766397688,"startTime":"0","endTime":"0","summary":"证券之星消息，12月22日诺唯赞发布公告《诺唯赞:诺唯赞关于持股5%以上股东权益变动触及1%刻度的提示性公告》，其股东国寿成达(上海)健康产业股权投资中心(有限合伙)于2025年11月12日至2025年12月19日间合计减持318.58万股，占公司目前总股本的0.801%，变动期间该股股价下跌14.87%，截止12月19日收盘报20.15元。股东增减持详情见下表：根据诺唯赞2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200023109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"gpt_icon":0},{"id":"2592916149","title":"诺唯赞（688105）披露公司产品取得欧盟CE IVDR认证，12月17日股价下跌0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592916149","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592916149?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:44","pubTimestamp":1765982676,"startTime":"0","endTime":"0","summary":"截至2025年12月17日收盘，诺唯赞报收于19.95元，较前一交易日下跌0.1%，最新总市值为79.35亿元。公司近日发布公告称，南京诺唯赞生物科技股份有限公司六项呼吸道病原体检测试剂盒获得欧盟CE IVDR认证，可在欧盟国家及认可欧盟CE认证的国家销售。本次认证表明公司质量管理体系符合欧盟要求，有助于提升公司国际市场竞争能力，但具体销售情况受多种因素影响，尚无法预测对未来业绩的影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700040408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["FSXEmain","FESXmain","688105","BK0216"],"gpt_icon":0},{"id":"2592696778","title":"诺唯赞(688105.SH)六项呼吸道病原体核酸检测试剂盒取得欧盟CE IVDR认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2592696778","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592696778?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:13","pubTimestamp":1765959238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺唯赞(688105.SH)公告，公司六项呼吸道病原体核酸检测试剂盒于近日取得欧盟CE IVDR认证，可在欧盟国家和认可欧盟CE认证的国家进行销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","CE","FESXmain","688105","BK4585","FSXEmain","BK4588","BK4109"],"gpt_icon":0},{"id":"2589339323","title":"诺唯赞（688105）披露控股子公司增资扩股暨引入外部投资者公告，12月08日股价下跌0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589339323","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589339323?lang=zh_cn&edition=full","pubTime":"2025-12-08 17:52","pubTimestamp":1765187570,"startTime":"0","endTime":"0","summary":"截至2025年12月8日收盘，诺唯赞报收于21.83元，较前一交易日下跌0.14%，最新总市值为86.83亿元。该股当日开盘21.96元，最高22.08元，最低21.73元，成交额达2658.02万元，换手率为0.31%。公司近日发布公告称，南京诺唯赞生物科技股份有限公司于2025年12月5日召开2025年第二次临时股东会，审议通过《关于控股子公司增资扩股暨引入外部投资者且公司为控股子公司提供担保的议案》。议案获得普通股股东99.9545%同意，中小投资者同意比例为99.2253%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800022650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"gpt_icon":0},{"id":"2588725701","title":"诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，12月1日股价下跌1.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588725701","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588725701?lang=zh_cn&edition=full","pubTime":"2025-12-01 17:55","pubTimestamp":1764582938,"startTime":"0","endTime":"0","summary":"截至2025年12月1日收盘，诺唯赞报收于22.53元，较前一交易日下跌1.14%，最新总市值为89.61亿元。近日，诺唯赞发布关于以集中竞价交易方式回购公司股份的进展公告。公告显示，南京诺唯赞生物科技股份有限公司于2025年6月19日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案，回购金额为500万元至1000万元，用于员工持股计划或股权激励，回购价格不超过30元/股，实施期限为2025年6月19日至2026年6月18日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100023726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"gpt_icon":0},{"id":"2586326310","title":"诺唯赞（688105）披露控股子公司增资扩股暨引入外部投资者公告，11月26日股价上涨0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586326310","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586326310?lang=zh_cn&edition=full","pubTime":"2025-11-26 22:43","pubTimestamp":1764168201,"startTime":"0","endTime":"0","summary":"截至2025年11月26日收盘，诺唯赞报收于22.73元，较前一交易日上涨0.26%，最新总市值为90.41亿元。公告显示，诺唯赞的控股子公司液滴英国拟进行增资扩股，引入国君创投SPV、南京市紫金生物医药产业投资基金、九安香港、华西银峰投资等外部投资者，合计投资金额包括人民币和美元。本次增资完成后，诺唯赞对液滴英国的持股比例将降至56.99%，液滴英国仍为公司合并报表范围内的控股子公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600039277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774147744594,"stockEarnings":[{"period":"1week","weight":-0.0234},{"period":"1month","weight":-0.0549},{"period":"3month","weight":-0.0253},{"period":"6month","weight":-0.1125},{"period":"1year","weight":-0.1634},{"period":"ytd","weight":-0.019}],"compareEarnings":[{"period":"1week","weight":-0.0338},{"period":"1month","weight":-0.0306},{"period":"3month","weight":0.0171},{"period":"6month","weight":0.0359},{"period":"1year","weight":0.1608},{"period":"ytd","weight":-0.003}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京诺唯赞生物科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"9447人(较上一季度增加9.90%)","perCapita":"42101股","listingDate":"2021-11-15","address":"江苏省南京市栖霞区经济技术开发区科创路红枫科技园C1-2栋东段1-6层","registeredCapital":"39773万元","survey":" 南京诺唯赞生物科技股份有限公司的主营业务是酶、抗原、抗体等生物制品的研发、生产和销售。公司的主要产品是生物试剂、POCT诊断试剂和仪器。截至2025年6月30日，公司共获得121项发明专利授权，发明专利申请累计269项。","listedPrice":55},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺唯赞(688105)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺唯赞(688105)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺唯赞,688105,诺唯赞股票,诺唯赞股票老虎,诺唯赞股票老虎国际,诺唯赞行情,诺唯赞股票行情,诺唯赞股价,诺唯赞股市,诺唯赞股票价格,诺唯赞股票交易,诺唯赞股票购买,诺唯赞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺唯赞(688105)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺唯赞(688105)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}